Extensive Limb Swelling after Immunization: Reports to the Vaccine Adverse Event Reporting System
- 1 August 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (3) , 351-358
- https://doi.org/10.1086/375820
Abstract
Extensive limb swelling (ELS) has been reported after vaccination with a limited number of vaccine types. We sought to describe vaccine types involved in and the clinical characteristics of ELS cases reported to the Vaccine Adverse Event Reporting System (VAERS). A case of ELS was defined as any report of edema extending at least to the elbow or knee of a vaccinated extremity. Four hundred ninety-seven cases were identified, with some describing swelling from the shoulder to the hand or the hip to the foot. Patient age ranged from 0.1 to 91 years. The proportion of reports of ELS associated with a given vaccine, among all VAERS reports received for that vaccine, varied substantially among vaccines. Most reactions began within 1 day after vaccination and involved other signs of inflammation. Postvaccination ELS can involve both the proximal and distal segments of the extremity, affects all age groups, and occurs after vaccination with a broad range of vaccines.Keywords
This publication has 9 references indexed in Scilit:
- Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoidsThe Pediatric Infectious Disease Journal, 2002
- Monitoring the Safety of VaccinesDrug Safety, 2002
- Safety and Immunogenicity of Six Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fifth Dose in Four- to Six-Year-Old ChildrenPediatrics, 2000
- Extensive Swelling After Booster Doses of Acellular Pertussis–Tetanus–Diphtheria VaccinesPediatrics, 2000
- A Safety and Immunogenicity Comparison of 12 Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fourth Dose in 15- to 20-Month-Old ChildrenPediatrics, 1997
- Immunogenicity and Reactogenicity of Takeda Acellular Pertussis-Component Diphtheria-Tetanus-Pertussis Vaccine in 2- and 3-Month-Old Children in JapanArchives of Pediatrics & Adolescent Medicine, 1992
- Acellular and Whole-Cell Pertussis Vaccines in JapanJAMA, 1987
- Severe Local Reactions to Pneumococcal VaccineSouthern Medical Journal, 1980
- Field Evaluation of a Human Anthrax VaccineAmerican Journal of Public Health and the Nations Health, 1962